All articles tagged with #brain organoids
UC Santa Cruz researchers showed that lab-grown brain organoids can process information and, with targeted electrical feedback guided by a reinforcement-learning algorithm, solve the cart-pole balancing task, boosting success from 4.5% to 46%. The work demonstrates goal-directed learning in minimal cortical circuits and marks a milestone in organoid neuroscience.
Mouse brain organoids grown in a dish were used in a closed-loop system with performance-based electrical feedback to train them to balance a virtual cartpole, achieving 46% proficiency under adaptive coaching. The results demonstrate short-term learning in neural tissue and offer a platform to study plasticity and neurological disease, while noting that the organoids are not conscious and the approach is not a replacement for traditional computing.
As AI and neurotechnology accelerate, scientists warn that a lack of a solid understanding of consciousness could trigger ethical and legal mistakes. A Frontiers in Science review argues for developing evidence-based tests to detect consciousness in humans, fetuses, animals, brain organoids, and AI, with wide implications for medicine, law, animal welfare, and policy, and calls for coordinated, phenomenology-focused research amid ongoing debates about whether machines could be conscious.
Scientists at Johns Hopkins have used lab-grown 'mini-brains' or organoids to identify neural signatures associated with schizophrenia and bipolar disorder, achieving up to 92% accuracy in distinguishing these conditions through electrical activity patterns, which could lead to more objective diagnoses and targeted treatments in the future.
Researchers have developed mini brain organoids from patient cells that exhibit distinct electrical activity patterns, enabling accurate identification of schizophrenia and bipolar disorder, which could lead to improved diagnosis and personalized treatment options.
Scientists have developed complex brain organoids that mimic a kindergartner's neural wiring, raising ethical concerns about their potential to develop sensations or consciousness. Experts advocate for global regulation to oversee research, especially as these mini brains could lead to breakthroughs in treating neurological disorders, but also pose moral questions about their use and treatment.
Scientists used lab-grown brain organoids and machine learning to identify distinct electrical signatures associated with schizophrenia and bipolar disorder, potentially paving the way for more accurate diagnoses and personalized treatments.
As brain organoids become more complex and closer to mimicking human brain functions, leading scientists and bioethicists are calling for an international oversight body to address emerging ethical concerns, including potential consciousness, rights of cell donors, and animal welfare, amid rapid advancements and increased funding in the field.
A Live Science poll reveals public uncertainty about experimenting on potentially conscious brain organoids, with opinions divided on ethical considerations and regulatory needs, highlighting the moral dilemma posed by advancing brain research.
Researchers at the University of Bergen have developed mini-brains, or brain organoids, to study mitochondrial dysfunction in brain cells, offering new insights into treating conditions like epilepsy, Alzheimer's, and Parkinson's diseases. These organoids mimic disease processes, allowing for real-time observation and testing of potential treatments, potentially revolutionizing the understanding and treatment of mitochondrial brain disorders.
Scientists have successfully grown human brain organoids in space aboard the International Space Station, significantly speeding up the process compared to Earth. This advancement allows for more accurate testing of new gene therapy treatments for neurological diseases like Alzheimer's and Parkinson's. The research, conducted by Axonis Therapeutics, uses reprogrammed viruses to deliver beneficial genes to central nervous system cells, potentially offering new treatments for currently untreatable conditions.
Researchers are developing the world's first "living processor" using human brain organoids, which could significantly reduce the energy demands of large artificial neural networks. The project, led by Swiss startup FinalSpark, is in its early stages and aims to achieve this ambitious goal through international collaboration. The platform allows universities to conduct long-term experiments on biological neural networks, with the potential to revolutionize energy-efficient computing.
Researchers at the University of California San Diego have identified the gene GTF2I as a key factor in social behavior, shedding light on its role in Williams syndrome and autism spectrum disorders. Using brain organoids, they found that the absence of GTF2I led to neural development issues and synaptic defects, offering potential insights into social behavior variations and the development of treatments for social impairments associated with autism. The study also contributes to our understanding of human social evolution and cooperation, highlighting the gene's central role in fetal brain development and its impact on socialization.
Scientists at the University of Wisconsin–Madison have successfully created the first 3D-printed brain organoids that function like natural brain tissue, allowing neurons to communicate, send signals, and form networks with support cells. This breakthrough could revolutionize neuroscience research, offering new opportunities to study diseases, test drugs, and understand how brain cells and parts of the brain communicate in humans. The researchers hope that their technique will be adopted by other labs and could lead to significant advancements in stem cell biology, neuroscience, and the understanding of neurological and psychiatric disorders.
Scientists have developed brain organoids from human fetal brain tissue, offering new insights into brain development and disease modeling. These 3D mini-organs could revolutionize research in neurology and oncology, as they closely mimic the complexity of the brain and can be used to study brain development and diseases, including brain tumors. The organoids were grown from small pieces of fetal brain tissue, self-organizing into complex 3D structures containing various brain cells. They also showed potential for modeling brain cancer and responding to cancer drugs, providing a valuable tool for studying the human brain and its diseases.